![]() Ainos Ainos (formerly known as Amarillo Biosciences) is a healthcare company that specializes in the development of novel biopharmaceuticals, medical treatments, and specialty consumer products. | ![]() Aerie Pharmaceuticals Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. | ![]() Olpha Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products. | |
Founding Date | Founding Date 1984 | Founding Date 2005 | Founding Date 1972 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Amarillo, US HQ Taipei, TW | Locations Irvine, US HQ Dublin, IE 千代田区, JP Henley On Thames, GB Bedminster, US Durham, US | Locations Olaine, LV HQ |
Employees | Employees 4326% increase | Employees 3808% increase | Employees 2,191 |
Valuation ($) | Valuation ($) 4.4 m | Valuation ($) 722.2 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $124.2k (FY, 2025) | Revenue (est.) $194.1m (FY, 2021) | Revenue (est.) €122.2m (FY, 2020) |
Cost of goods | Cost of goods $21.2k (FY, 2025) | Cost of goods $26.8m (FY, 2021) | Cost of goods €44.5m (FY, 2020) |
Gross profit | Gross profit $102.9k (FY, 2025) | Gross profit N/A | Gross profit €80.1m (FY, 2020) |
Net income | Net income ($14.8m) (FY, 2025) | Net income ($74.8m) (FY, 2021) | Net income €9.5m (FY, 2020) |

Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
View company
Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products.
View company